More COVID vaccine megasites open nationwide, including at Yankee Stadium
More than 36 million vaccine shots currently on the market have been administered nationwide, and 7.5 million people are now fully vaccinated.
COVID-19 Vaccine
FDA considers Johnson & Johnson vaccine
The Biden administration is ramping up efforts to distribute and administer coronavirus vaccinations. Meanwhile, the FDA considers whether to give Johnson & Johnson's COVID-19 vaccine emergency use approval. Jodie Guest, a professor and Emory University's Department of Epidemiology vice chair, speaks to CBSN's Lana Zak about how it could be a game-changer in the fight against COVID-19.
Super Bowl to honor frontline workers
The NFL will kick off the Super Bowl LV celebrations with a tribute to the nation's healthcare heroes. The league selected 7,500 vaccinated frontline workers from across the United States and awarded them free tickets to the big game. Married couple Dr. Andrea Buras, a gynecologic oncologist, and Dr. Ryan Kenney, an emergency medicine physician, spoke with Lana Zak about the significance of going to the game.
Health experts caution against Super Bowl parties
Concerns are mounting that the Super Bowl could become the next super-spreader event. Health experts are warning against large gatherings as the U.S. works to get ahead of emerging variants. Dr. Teresa Amato, the director of emergency medicine at Long Island Jewish Forest Hills, joins CBSN with more on how to celebrate safely.
Doctor on COVID-19 variants, J&J's vaccine
A third coronavirus vaccine could be available in the U.S. by the end of the month. Johnson and Johnson has asked the Food and Drug Administration to authorize its vaccine for emergency use. "CBS This Morning" lead national correspondent David Begnaud reports several of the new variants of the virus are spreading, and CBSN's Tanya Rivero spoke with infectious disease specialist Dr. Uzma Syed, director of the Antimicrobial Stewardship Center of Excellence at Good Samaritan Hospital Medical Center in New York.
Johnson & Johnson seeks vaccine approval
Johnson and Johnson asked the Food and Drug Administration for emergency-use authorization for its COVID-19 vaccine. Meanwhile on Capitol Hill, the Senate moved forward with a process that would allow Democrats to approve a relief bill without Republican support. CBS News' Debra Alfarone joined "CBSN AM" from Capitol Hill to discuss.
Health care workers going to Super Bowl
About 7,500 vaccinated health care workers from across the nation will attend Sunday's Super Bowl. They include a Florida nurse who's a Tampa Bay Buccaneers fan and a New York chaplain who's a Kansas City Chiefs fan. They opened up about their experiences ahead of the big game, and CBS News' Skyler Henry joined "CBSN AM" to discuss.
Johnson & Johnson seeks U.S. approval for one-dose COVID vaccine
A possible third COVID vaccine could be on the way in the U.S. — and it's sorely needed as coronavirus variants continue to spread.
Inequities in U.S. vaccine distribution
The pace of COVID-19 vaccine distribution is steadily rising in the U.S., but there are still concerns about inequities. CBS News' David Begnaud reports on the rollout, and Dr. Julie Morita, executive vice president of the Robert Wood Johnson Foundation and former member of the Biden administration's transition advisory board, joins CBSN's Tanya Rivero to discuss what the nation needs to do to ensure the most vulnerable populations aren't left behind.
U.K. study to test giving doses of two different COVID vaccines
If effective, mixing the shots might provide more flexibility in vaccine rollout – and it may even give a person better protection, scientists say.
U.K. says vaccine upgrades coming as 4,000 COVID variants circulate
The U.K.'s vaccine deployment minister says current vaccines should help control variants, but all vaccine makers are "looking at how they can improve" formulas.
Misinformation about COVID vaccine and infertility raises alarm
One fertility doctor in New Orleans is asked daily if the vaccine causes infertility. He said there's no evidence of that happening.
Biden believes GOP will support relief plan
President Biden met with top Senate Democrats at the White House on Wednesday to discuss his coronavirus relief plan. CBS News political contributor and Washington Post White House reporter Sean Sullivan and CBS News political contributor Molly Hooper joins CBSN's Elaine Quijano to discuss.
AstraZeneca vaccine shows promise
New research suggests the Oxford-AstraZeneca coronavirus vaccine can not only prevent people from getting sick, it could also help reduce the spread of the virus. The news comes as concerns grow that new virus variants will make vaccines less effective. Dr. Leo Nissola, an immunotherapy scientist and advisor to the nonprofit COVID Act Now, discusses the spread of new virus mutations and the significance of the AstraZeneca vaccine.
Oxford: Vaccine could curb not only illness, but spread of COVID-19
Oxford/AstraZeneca trial data is first to suggest a vaccine prevents asymptomatic infection, which the U.K.'s leader calls an "absolutely superb" development.
U.K.'s COVID variant hunters warn U.S. mutations could be widespread
Britain leads the world in tracking down new strains of the disease, and scientists keep finding worrying new mutations — but at least they're finding them.
Turkey banking on a Chinese vaccine in its battle against COVID-19
Mixed trial results have left doubt over the efficacy of China's "CoronaVac" vaccine, but while Turks have low trust, they also have no options.
Dems and GOP split on COVID relief costs
Senate Democrats are moving forward with a plan to pass President Biden's $1.9 trillion coronavirus relief plan. Democrats are attempting to pass the bill, which has no Republican support, with a simple majority through reconciliation. Wall Street Journal congressional reporter Siobhan Hughes and Reuters White House correspondent Jeff Mason join CBSN's Elaine Quijano to discuss.
Vaccine hesitancy among health care workers
Roughly one-third of people who work in healthcare settings want to “wait and see” before getting a COVID-19 vaccine. Adriana Diaz visits a Chicago hospital where 73% of the staff has declined the vaccine to find out why they’re so hesitant.
Biden pushes for vaccine accessibility
The Biden administration says it will start shipping coronavirus vaccines to retail pharmacies starting next week. The move is meant to make the vaccine more accessible to the American public, particularly in communities of color, which have had problems accessing the COVID-19 vaccine. Politico’s White House correspondent and co-author of the Playbook Newsletter Eugene Daniels joins CBSN to discuss how Vice President Kamala Harris has been tasked with boosting confidence in the vaccine in communities of color across the country.
COVID-19 vaccines to roll out to pharmacies
New COVID-19 cases have finally started to decline in the United States, but concerns a rising over more contagious variants. Dr. Robert Glatter, an emergency physician at Lenox Hill Hospital, joined CBSN's Tanya Rivero to discuss what the U.S. needs to do to get the pandemic under control.
Peer-reviewed study finds Russia's COVID vaccine is 91.6% effective
Some experts say The Lancet study, based on data from a large-scale human trial in Moscow, should end skepticism over the vaccine.
U.S. closing in on 50 million vaccine doses — who's getting them?
The CDC has released its first comprehensive look at the state of the nationwide vaccine campaign so far.
Pregnant women concerned about COVID vaccine over lack of data
Pregnant women face a dilemma in deciding whether to get vaccinated because they were excluded from initial trials.
Biden vaccination plan facing obstacles
Even before he took office, President Biden promised to deliver 100 million coronavirus vaccine doses during his first 100 days in office. But the administration does not seem to have hit the ground running as quickly as they hoped. Isaac Stanley-Becker, a national political reporter with the Washington Post, discusses the rollout of the Biden administration's pandemic response plan and what it must do to stay on track with meeting its goals.
How Charlie Kirk's assassination portends a national crisis
The murder of Charlie Kirk last week follows a litany of violent acts against political targets. Historian Jon Meacham talks about the existential questions now facing America.
Colorado school shooter had account on "violent gore" site, ADL says
Desmond Holly and several school shooters in the past year were active on the same website, the ADL says.
Sen. Chris Coons: The internet "is driving extremism in our country"
In a joint segment with Republican Sen. James Lankford, Democratic Sen. Chris Coons said amid efforts to foster bipartisan discourse, the internet "is driving extremism in our country."
Ukrainian drones target one of Russia's top oil refineries
The strike on the Kirishi refinery, in Russia's northwestern Leningrad region, follows weeks of Ukrainian attacks on Russian oil infrastructure that Kyiv says fuels Moscow's war effort.
White House requests $58 million to increase security for executive, judicial branches
A White House official confirmed the extra funds would be directed to the U.S. Marshals Service and would also include enhanced protection for Supreme Court justices.
California legislature votes to phase out "forever chemicals" in cookware
California lawmakers voted to phase out a group of chemicals known as PFAS, which are often called "forever chemicals," in cookware.
Venezuela accuses U.S. of seizing fishing boat in Caribbean amid standoff
Venezuela's foreign ministry said nine fishermen were "illegally and hostilely" detained on Friday by the USS Jason Dunham.
Ex-world boxing champion Ricky Hatton found dead at age 46
Ricky Hatton shared the ring with the best boxers of his generation, including Kostya Tszyu, Floyd Mayweather and Manny Pacquiao.
Details emerge about Charlie Kirk shooting suspect. Here's what we know.
Conservative activist Charlie Kirk was shot and killed on Wednesday while speaking an event at Utah Valley University.